Aspect Medical Systems 8-K 2009
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): June 30, 2009
Aspect Medical Systems, Inc.
(Exact Name of Registrant as Specified in Charter)
Registrants telephone number, including area code: (617) 559-7000
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
TABLE OF CONTENTS
Item 1.01. Entry into a Material Definitive Agreement
On June 30, 2009, Aspect Medical Systems, Inc. (the Company) entered into a Sixteenth Amendment to Loan Agreement (the Amendment) with Bank of America, N.A. (successor by merger to Fleet National Bank) (the Lender) to the letter agreement dated May 16, 2001, as amended (the Loan Agreement).
Pursuant to the Amendment:
This summary description of the Amendment does not purport to be complete and is qualified in its entirety by reference to the Amendment, which is attached hereto as Exhibit 10.1 and is incorporated herein by reference.
Item 2.03. Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
See the description set forth under Item 1.01 Entry into a Material Definitive Agreement, which is incorporated into this Item 2.03 by reference.
Item 9.01. Financial Statements and Exhibits
(d) See Exhibit Index attached hereto.
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.